Lung Cancer Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065232
  • May 2021
  • Pharmaceuticals
  • 142 Pages
The Lung Cancer Therapeutics market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Lung Cancer Therapeutics market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Astellas Pharma, Pfizer, Amgen, Celgene, AstraZeneca, F. HofmannLa Roche, GlaxoSmithKline, Aetna, Agennix, Eli Lilly, Boston Biomedical
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Lung Cancer Therapeutics market along with their effects over the forecast period. Similarly, according to the region Lung Cancer Therapeutics market research report includes the study of opportunities available in the market situation.

The Lung Cancer Therapeutics market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Lung Cancer Therapeutics Market:
The Lung Cancer Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Astellas Pharma, Pfizer, Amgen, Celgene, AstraZeneca, F. HofmannLa Roche, GlaxoSmithKline, Aetna, Agennix, Eli Lilly, Boston Biomedical

Lung Cancer Therapeutics Market Segmentation Analysis:
by Disease Type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Molecule Type
Small molecules
Biologics

Global Lung Cancer Therapeutics Market Segmentation by Regions:
In regional analysis, Lung Cancer Therapeutics market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Lung Cancer Therapeutics market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Lung Cancer Therapeutics Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Lung Cancer Therapeutics Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Lung Cancer Therapeutics Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Lung Cancer Therapeutics Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Lung Cancer Therapeutics Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Lung Cancer Therapeutics market, according to the key region.
  • To study the Lung Cancer Therapeutics market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Lung Cancer Therapeutics market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Lung Cancer Therapeutics research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Lung Cancer Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Lung Cancer Therapeutics market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Lung Cancer Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Lung Cancer Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Lung Cancer Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Astellas Pharma
  • Pfizer
  • Amgen
  • Celgene
  • AstraZeneca
  • F. HofmannLa Roche
  • GlaxoSmithKline
  • Aetna, Agennix
  • Eli Lilly
  • Boston Biomedical
  • Non-Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Small molecules
  • Biologics

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Lung Cancer Therapeutics Market Snapshot
          2.1.1. Global Lung Cancer Therapeutics Market By Disease Type,2019
               2.1.1.1.Non-Small Cell Lung Cancer
               2.1.1.2.Small Cell Lung Cancer
          2.1.2. Global Lung Cancer Therapeutics Market By Molecule Type,2019
               2.1.2.1.Small molecules
               2.1.2.2.Biologics
          2.1.3. Global Lung Cancer Therapeutics Market By End-use,2019
          2.1.4. Global Lung Cancer Therapeutics Market By Geography,2019

3. Global Lung Cancer Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Disease Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Disease Type, 2020
     4.2. Global Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028

5. Global Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Molecule Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Molecule Type, 2020
     5.2. Global Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028

6. Global Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Lung Cancer Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Lung Cancer Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Lung Cancer Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028
          7.2.3. North America Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028
          7.2.4. North America Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Lung Cancer Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Lung Cancer Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028
          7.3.3. Europe Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028
          7.3.4. Europe Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Lung Cancer Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Lung Cancer Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028
          7.4.3. Asia Pacific Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028
          7.4.4. Asia Pacific Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Lung Cancer Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Lung Cancer Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028
          7.5.3. Latin America Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028
          7.5.4. Latin America Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Lung Cancer Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Lung Cancer Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Lung Cancer Therapeutics Market Size (US$), By Disease Type, 2018 – 2028
          7.6.3. MEA Lung Cancer Therapeutics Market Size (US$), By Molecule Type, 2018 – 2028
          7.6.4. MEA Lung Cancer Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Lung Cancer Therapeutics Providers
        8.4.1 Astellas Pharma
                8.4.1.1 Business Description
                8.4.1.2 Astellas Pharma Geographic Operations
                8.4.1.3 Astellas Pharma Financial Information
                8.4.1.4 Astellas Pharma Product Positions/Portfolio
                8.4.1.5 Astellas Pharma Key Developments
        8.4.2 Pfizer
                8.4.2.1 Business Description
                8.4.2.2 Pfizer Geographic Operations
                8.4.2.3 Pfizer Financial Information
                8.4.2.4 Pfizer Product Positions/Portfolio
                8.4.2.5 Pfizer Key Developments
        8.4.3 Amgen
                8.4.3.1 Business Description
                8.4.3.2 Amgen Geographic Operations
                8.4.3.3 Amgen Financial Information
                8.4.3.4 Amgen Product Positions/Portfolio
                8.4.3.5 Amgen Key Developments
        8.4.4 Celgene
                8.4.4.1 Business Description
                8.4.4.2 Celgene Geographic Operations
                8.4.4.3 Celgene Financial Information
                8.4.4.4 Celgene Product Positions/Portfolio
                8.4.4.5 Celgene Key Developments
        8.4.5 AstraZeneca
                8.4.5.1 Business Description
                8.4.5.2 AstraZeneca Geographic Operations
                8.4.5.3 AstraZeneca Financial Information
                8.4.5.4 AstraZeneca Product Positions/Portfolio
                8.4.5.5 AstraZeneca Key Developments
        8.4.6 F. HofmannLa Roche
                8.4.6.1 Business Description
                8.4.6.2 F. HofmannLa Roche Geographic Operations
                8.4.6.3 F. HofmannLa Roche Financial Information
                8.4.6.4 F. HofmannLa Roche Product Positions/Portfolio
                8.4.6.5 F. HofmannLa Roche Key Developments
        8.4.7 GlaxoSmithKline
                8.4.7.1 Business Description
                8.4.7.2 GlaxoSmithKline Geographic Operations
                8.4.7.3 GlaxoSmithKline Financial Information
                8.4.7.4 GlaxoSmithKline Product Positions/Portfolio
                8.4.7.5 GlaxoSmithKline Key Developments
        8.4.8 Aetna, Agennix
                8.4.8.1 Business Description
                8.4.8.2 Aetna, Agennix Geographic Operations
                8.4.8.3 Aetna, Agennix Financial Information
                8.4.8.4 Aetna, Agennix Product Positions/Portfolio
                8.4.8.5 Aetna, Agennix Key Developments
        8.4.9 Eli Lilly
                8.4.9.1 Business Description
                8.4.9.2 Eli Lilly Geographic Operations
                8.4.9.3 Eli Lilly Financial Information
                8.4.9.4 Eli Lilly Product Positions/Portfolio
                8.4.9.5 Eli Lilly Key Developments
        8.4.10 Boston Biomedical
                8.4.10.1 Business Description
                8.4.10.2 Boston Biomedical Geographic Operations
                8.4.10.3 Boston Biomedical Financial Information
                8.4.10.4 Boston Biomedical Product Positions/Portfolio
                8.4.10.5 Boston Biomedical Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Lung Cancer Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Lung Cancer Therapeutics Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Lung Cancer Therapeutics Market Revenue, By Molecule Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Lung Cancer Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Lung Cancer Therapeutics Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Lung Cancer Therapeutics Market Revenue, By Molecule Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Lung Cancer Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Lung Cancer Therapeutics Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Lung Cancer Therapeutics Market Revenue, By Molecule Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Lung Cancer Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Lung Cancer Therapeutics Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Lung Cancer Therapeutics Market Revenue, By Molecule Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Lung Cancer Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Lung Cancer Therapeutics Market Revenue, By Disease Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Lung Cancer Therapeutics Market Revenue, By Molecule Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Lung Cancer Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Lung Cancer Therapeutics: Market Segmentation 
FIG. 2 Global Lung Cancer Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Lung Cancer Therapeutics Market, By Disease Type, 2019 (US$ Mn) 
FIG. 5 Global Lung Cancer Therapeutics Market, By Molecule Type, 2019 (US$ Mn) 
FIG. 6 Global Lung Cancer Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Lung Cancer Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Lung Cancer Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Lung Cancer Therapeutics Providers, 2019
FIG. 11 Global Lung Cancer Therapeutics Market Revenue Contribution, By Disease Type, 2019 & 2028 (Value %) 
FIG. 12 Global Lung Cancer Therapeutics Market Revenue Contribution, By Molecule Type, 2019 & 2028 (Value %) 
FIG. 13 Global Lung Cancer Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Lung Cancer Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Lung Cancer Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Lung Cancer Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Lung Cancer Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Lung Cancer Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Lung Cancer Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Lung Cancer Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Lung Cancer Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Lung Cancer Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Lung Cancer Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Lung Cancer Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Lung Cancer Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Lung Cancer Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Lung Cancer Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Lung Cancer Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Lung Cancer Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Lung Cancer Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Lung Cancer Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Lung Cancer Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Lung Cancer Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Lung Cancer Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Lung Cancer Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Astellas Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. HofmannLa Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aetna, Agennix: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boston Biomedical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Lung Cancer Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Lung Cancer Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Lung Cancer Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Lung Cancer Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Lung Cancer Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Lung Cancer Therapeutics Providers, 2016
FIG.  Global Lung Cancer Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Small Cell Lung Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Lung Cancer Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Lung Cancer Therapeutics Market Value, 2018 – 2028, (US$ Mn)